Avita Medical share price on watch after being added to the ASX 200

The Avita Medical Ltd (ASX:AVH) share price could be on the rise today after the medical technology company was added to the ASX 200 index…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Avita Medical Ltd (ASX: AVH) share price could push higher on Friday after it became the latest addition to the ASX 200 index.

Why is Avita Medical joining the ASX 200?

After the market close on Thursday, S&P Dow Jones Indices announced that it will remove Aveo Group (ASX: AOG) from the S&P/ASX 200 on November 14.

This is because earlier in the week the retirement communities company's shareholders voted in favour of the scheme of arrangement that will see Brookfield Asset Management Inc acquire 100% of Aveo.

Brookfield Asset Management will pay a total consideration of $2.195 per share to Aveo shareholders. This is inclusive of the FY 2019 final distribution of 4.5 cents per security.

Whilst there were a good number of candidates to replace Aveo in the benchmark index, S&P Dow Jones Indices elected to choose Avita Medical.

This caps off a remarkable year for Avita Medical and its shareholders. On January 1 the medical technology company's shares were largely under the radar of most investors and changing hands at just 8 cents. Now they are trading 719% higher at 65.5 cents, giving it a market capitalisation of ~$1.2 billion.

What is Avita Medical?

Avita Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration.

The company's FDA-approved RECELL System is indicated for use in the treatment of acute thermal burns in patients 18 years and older. It is used to prepare Spray-On Skin Cells using a small amount of a patient's own skin. This provides a new way to treat severe burns, while significantly reducing the amount of donor skin required.

A series of clinical trials in major U.S. burn centres have shown that the system is a significant advancement over the current standard of care for burn patients and offers benefits in clinical outcomes and cost savings.

Unsurprisingly, this has led to the company recording very strong sales growth in FY 2020. Last month it reported first quarter sales of A$7.9 million, up 165% on the prior corresponding period.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Animation of a man measuring a percentage sign, symbolising rising interest rates.
Share Market News

Here's when Westpac says the RBA will now cut interest rates

Will borrowers need to wait until the middle of next year for relief? Let's find out.

Read more »

Boys making faces and flexing.
Opinions

3 ASX 300 shares to buy and hold for the long run

I believe these stocks have loads of growth potential.

Read more »

Young girl drinking milk showing off muscles.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great end to the trading week for ASX investors today.

Read more »

Hands reaching high for a trophy with a sunset in the background.
Record Highs

The ASX 200 Index is on its way to another all-time high today. Here's why

These blue chip stocks are driving the index towards a new record today...

Read more »

Group of friends trading stocks on their phones. symbolising the 3 most traded ASX 200 shares today
Share Market News

3 ASX mining stocks topping the most-traded list in October

Chinese stimulus news and company announcements likely contributed to the higher trading activity.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Share Gainers

3 ASX 200 stocks smashing the benchmark this week

These three ASX 200 stocks are leading the charge this week. Here’s how.

Read more »

Two people tired and resting after sports race.
Broker Notes

Fundie rates 2 ASX 200 stocks in short-term pain but with long-term gain potential

Blackwattle Investment Partners sees these 2 ASX 200 stocks as worthy of a buy and hold strategy.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why A2 Milk, EOS, GQG, and Mineral Resources shares are racing higher today

These shares are ending the week strongly. But why?

Read more »